Integrin inhibitor, GLPG0187, Purity ≥98%

Cat. No.: X24-08-YM287

Integrin inhibitor, GLPG0187, Purity ≥98%

Synonym: 1320346-97-1; GLPG 0187; GLPG-0187; (2S)-3-[[2,5-Dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid

  • CAS Number: 1320346-97-1
  • Compound CID: 53340771
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
GLPG0187 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.
Molecular Weight
595.71
Molecular Formula
C29H37N7O5S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
GLPG0187 is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of fibrotic diseases and certain cancers by targeting αvβ6 integrin, which is involved in tissue fibrosis and cancer progression.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.